A potential correlation with tivantinib sensitivity could be amplification of GSK3α expression levels as GSK3α is more highly expressed in several different subtypes of AML, including 11q23 MLL-rearranged leukemia, which has previously been shown to be sensitive to GSK3 inhibition13,28. This evidence concerns the gene KMT2A and leukemia.